subject: Aeras Global Tb Vaccine Foundation - Pharmaceuticals & Healthcare [print this page] Summary Summary
Aeras Global TB Vaccine Foundation (Aeras) is a biotechnology company, based in the US. The company develops tuberculosis vaccines and distributes it to the healthcare markets. Its tuberculosis vaccine products include MVA85A, AERAS-402 / Crucell Ad35, GSK M72, SSI/SP H4-IC31 and SSI H56-IC31. The company supports the development of vaccines and other biopharmaceuticals to address TB and other public health needs. Its clinical trials are designed to test the safety and efficacy of vaccines before they are used in markets. The companys partners are Crucell, Emergent BioSolutions, GlaxoSmithKline Biologicals, Immune Solutions, ImmunoBiology, Intercell, Statens Serum Institut, Thymed, and others. Aeras is headquartered in Rockville, Maryland, the US.
Aeras Global Tb Vaccine Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
For more information visit : http://www.companyprofilesandconferences.com/researchindex/Pharmaceuticals-Healthcare-c13/Aeras-Global-Tb-Vaccine-Foundation-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile.html
Or
Contact us at
Company Profiles And Conferences
Phone: +91.22.27810772, 27810773
Fax: +91 22 27810778
Email : info@companyprofilesandconferences.com
Website : www.companyprofilesandconferences.com/
by: Companyprofiles
welcome to Insurances.net (https://www.insurances.net)
